June 25, 2012
A New Jersey federal judge on Friday preliminarily allowed Merck & Co. Inc. to pay $10.4 million to exit a class action filed by employees who say their retirement savings were hurt by the company's misrepresentations about the effectiveness of its cholesterol drug Vytorin.